Histological Confirmation of Clinical Clearance of Actinic Keratoses Following Treatment With Ingenol Mebutate Gel, 0.05%
- First Posted Date
- 2013-07-04
- Last Posted Date
- 2016-04-05
- Lead Sponsor
- LEO Pharma
- Target Recruit Count
- 137
- Registration Number
- NCT01892137
- Locations
- 🇩🇪
Klinik für Dermatologie & Allergologie Klinikum Augsburg Süd, Augsburg, Germany
🇩🇪Medizinisches Zentrum Bonn Friedensplatz, Bonn, Germany
🇦🇺St John of God Dermatology, Subiaco, Western Australia, Australia
LEO 90100 Compared to Vehicle in Subjects With Psoriasis Vulgaris
- First Posted Date
- 2013-05-31
- Last Posted Date
- 2019-09-18
- Lead Sponsor
- LEO Pharma
- Target Recruit Count
- 426
- Registration Number
- NCT01866163
- Locations
- 🇺🇸
Central Dermatology, Saint Louis, Missouri, United States
Safety, Tolerability and Pharmacokinetics in AD Subjects and Healthy Subjects of Cutaneous Application of LEO 39652 Cream
- First Posted Date
- 2013-05-10
- Last Posted Date
- 2015-01-22
- Lead Sponsor
- LEO Pharma
- Target Recruit Count
- 23
- Registration Number
- NCT01850849
- Locations
- 🇬🇧
Covance Clinical Research Unit, Hyde Street, Leeds, UK, Leeds, United Kingdom
🇬🇧Covance Royal Liverpool Clinical Research Unit, Liverpool, United Kingdom
An Exploratory Psoriasis Plaque Test Study With Different Dose Combinations of Calcipotriol Plus Betamethasone Dipropionate in the Daivobet® Gel Vehicle in Psoriasis Vulgaris
- Conditions
- Interventions
- First Posted Date
- 2013-04-23
- Last Posted Date
- 2013-07-23
- Lead Sponsor
- LEO Pharma
- Target Recruit Count
- 24
- Registration Number
- NCT01837576
- Locations
- 🇫🇷
Centre de harmacologie Clinique Appliquée à la Dermatologie (CPCAD), Nice, Nice Cedex 3, France
Safety and Efficacy of Ingenol Mebutate Once Daily for 2 or 3 Consecutive Days in Subjects With Actinic Keratosis
- First Posted Date
- 2013-03-28
- Last Posted Date
- 2021-05-25
- Lead Sponsor
- LEO Pharma
- Target Recruit Count
- 395
- Registration Number
- NCT01820260
- Locations
- 🇺🇸
Laser & Skin Surgery Center of Inidana, Carmel, Indiana, United States
Safety and Dose Finding Study of New Vehicle Formulations Containing Ingenol Mebutate to Treat Actinic Keratosis on the Forearm
- Conditions
- Interventions
- First Posted Date
- 2013-03-04
- Last Posted Date
- 2014-09-10
- Lead Sponsor
- LEO Pharma
- Target Recruit Count
- 37
- Registration Number
- NCT01803477
- Locations
- 🇦🇺
Dermatology Department, Woolloongabba, Queensland, Australia
🇦🇺Specialist Connect, Woolloongabba, Queensland, Australia
Prescription and Utilization of Low Molecular Weight Heparin in Usual Medical Practice for the Curative Treatment of Venous Thromboembolism in Patients With Cancer
- Conditions
- First Posted Date
- 2013-03-04
- Last Posted Date
- 2018-02-05
- Lead Sponsor
- LEO Pharma
- Target Recruit Count
- 419
- Registration Number
- NCT01803022
- Locations
- 🇫🇷
Hopital Saint Louis, Paris, France
A Simultaneous Treatment Regimen Compared to a Sequential Treatment Regimen With Ingenol Mebutate Gel 0.015% and 0.05% of Two Areas With Actinic Keratosis on Face/Scalp and Trunk/Extremities
- Conditions
- Interventions
- First Posted Date
- 2013-02-08
- Last Posted Date
- 2021-06-22
- Lead Sponsor
- LEO Pharma
- Target Recruit Count
- 200
- Registration Number
- NCT01787383
- Locations
- 🇮🇹
Clinica Dermatologica dell'Università di Modena e Reggio Emilia, Modena, Italy
The Pharmacokinetics of LEO 90105 (Calcipotriol Hydrate Plus Betamethasone Dipropionate) in Japanese Subjects With Extensive Psoriasis Vulgaris
- First Posted Date
- 2013-01-15
- Last Posted Date
- 2015-06-08
- Lead Sponsor
- LEO Pharma
- Target Recruit Count
- 13
- Registration Number
- NCT01768013
Cromoglicate in Psoriasis
- First Posted Date
- 2012-11-07
- Last Posted Date
- 2022-05-04
- Lead Sponsor
- LEO Pharma
- Target Recruit Count
- 30
- Registration Number
- NCT01722812
- Locations
- 🇩🇪
Allergie-Centrum-Charité, Department of Dermatology and Allergy, Charité - Universitätsmedizin Berlin, Berlin, Germany